These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34463271)

  • 1. Study on the potential nephrotoxicity and mutagenicity of aristolochic acid IVa and its mechanism.
    Xian Z; Tian J; Zhang Y; Meng J; Zhao Y; Li C; Yi Y; Han J; Liu S; Wang L; Pan C; Wang D; Wang F; Liang A
    Biomed Pharmacother; 2021 Oct; 142():112081. PubMed ID: 34463271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-carcinogenic/non-nephrotoxic aristolochic acid IVa exhibited anti-inflammatory activities in mice.
    Liu W; Shao F; You X; Cao Y; Xi J; Wu J; Wan J; Zhang X; Fei J; Luan Y
    J Nat Med; 2023 Mar; 77(2):251-261. PubMed ID: 36525161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity.
    Xian Z; Tian J; Zhao Y; Yi Y; Li C; Han J; Zhang Y; Wang Y; Wang L; Liu S; Pan C; Liu C; Wang D; Meng J; Tang X; Wang F; Liang A
    Phytomedicine; 2023 Jun; 114():154815. PubMed ID: 37062136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.
    Xue X; Gong LK; Maeda K; Luan Y; Qi XM; Sugiyama Y; Ren J
    Mol Pharm; 2011 Dec; 8(6):2183-92. PubMed ID: 21980933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.
    Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J
    Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aristolochic acid IVa forms DNA adducts in vitro but is non-genotoxic in vivo.
    Wan J; Chen R; Yang Z; Xi J; Cao Y; Chen Y; Zhang X; Luan Y
    Arch Toxicol; 2021 Aug; 95(8):2839-2850. PubMed ID: 34223934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of histone deacetylase-1 and p300 in aristolochic acid nephropathy models.
    Tian Y; Yang Y; Gao L; Zhao H; Peng X; Zhang Z; Wu G
    Toxicol Mech Methods; 2014 Sep; 24(6):377-84. PubMed ID: 24796935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective toxicity of aristolochic acids I and II.
    Shibutani S; Dong H; Suzuki N; Ueda S; Miller F; Grollman AP
    Drug Metab Dispos; 2007 Jul; 35(7):1217-22. PubMed ID: 17392392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.
    Arlt VM; Stiborova M; Schmeiser HH
    Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aristolochic acid I promoted clonal expansion but did not induce hepatocellular carcinoma in adult rats.
    Liu YZ; Lu HL; Qi XM; Xing GZ; Wang X; Yu P; Liu L; Yang FF; Ding XL; Zhang ZA; Deng ZP; Gong LK; Ren J
    Acta Pharmacol Sin; 2021 Dec; 42(12):2094-2105. PubMed ID: 33686245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
    Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute nephrotoxicity of aristolochic acids in mice.
    Sato N; Takahashi D; Chen SM; Tsuchiya R; Mukoyama T; Yamagata S; Ogawa M; Yoshida M; Kondo S; Satoh N; Ueda S
    J Pharm Pharmacol; 2004 Feb; 56(2):221-9. PubMed ID: 15005881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
    Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
    Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rhein and Rheum palmatum L. extract on the pharmacokinetics and tissue distribution of aristolochic acid I and its demethylated metabolite in rats.
    Ma L; Shen Z; Hu H; Zhou H; Yu L; Jiang H; Zeng S
    J Ethnopharmacol; 2021 Mar; 267():113537. PubMed ID: 33137430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers.
    Lu ZN; Luo Q; Zhao LN; Shi Y; Wang N; Wang L; Han ZG
    Hepatology; 2020 Mar; 71(3):929-942. PubMed ID: 31692012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro.
    Sborchia M; De Prez EG; Antoine MH; Bienfait L; Indra R; Valbuena G; Phillips DH; Nortier JL; Stiborová M; Keun HC; Arlt VM
    Arch Toxicol; 2019 Nov; 93(11):3345-3366. PubMed ID: 31602497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of REV-ERBα dysregulation and ferroptosis in aristolochic acid I-induced renal injury.
    Wang Y; Wang Z; Wu Z; Chen M; Dong D; Yu P; Lu D; Wu B
    Biochem Pharmacol; 2021 Nov; 193():114807. PubMed ID: 34673015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone I protects mice from aristolochic acid I-induced kidney injury by induction of CYP1A.
    Feng C; Xie X; Wu M; Li C; Gao M; Liu M; Qi X; Ren J
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):850-7. PubMed ID: 23981375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalin Protects Mice from Aristolochic Acid I-Induced Kidney Injury by Induction of CYP1A through the Aromatic Hydrocarbon Receptor.
    Wang K; Feng C; Li C; Yao J; Xie X; Gong L; Luan Y; Xing G; Zhu X; Qi X; Ren J
    Int J Mol Sci; 2015 Jul; 16(7):16454-68. PubMed ID: 26204831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.